Clinical Trials Browser

Phase 2 × NIH × LB100 × Clear all

NCT03027388 2023-11-22

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Phase 2 Completed

7 enrolled 20 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma